According to a report from Zhitung Finance APP, Sichuan Kelun Pharmaceutical (002422.SZ) announced that on November 28, 2024, the National Medical Insurance Administration and the Ministry of Human Resources and Social Security issued a notice on the publication of (Medical Insurance Issued [2024] No. 33). According to this notice, a total of 5 varieties of products from the company are included in the . The names of the pharmaceuticals are: Cefotetan Avibactam Sodium/Sodium Chloride Injection, Cefotetan/5% Glucose Injection, Bupivacaine Liposome Injection, ω-3 Fish Oil Medium/Long Chain Fat Emulsion Injection, and Medium-Long Chain Fat Emulsion/Amino Acids (16)/Glucose (36%) Injection.

The company's products included in the <2024 Pharmaceutical Catalog> will help promote the expansion of the company's market network and enhance sales scale, though the impact on the company's operational performance is currently difficult to estimate. The National Medical Insurance Catalog (2024) will officially implement on January 1, 2025. The reimbursement standards and details regarding medical insurance must be based on the information publicly announced by the National Medical Security Administration and other relevant government departments.